TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing November 16, 1979
TCL Archive National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report May 19, 2000
